The Spectrum and Frequency of Cystic Fibrosis Mutations in Albanian Patients
, , , et
06 sept. 2024
À propos de cet article
Catégorie d'article: Original Article
Publié en ligne: 06 sept. 2024
Pages: 31 - 36
DOI: https://doi.org/10.2478/bjmg-2024-0004
Mots clés
© 2024 I Kasmi et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Genotype variants and their frequency
87 | 75.00 | |
23 | 19.82 | |
F508del/G85E | 4 | 3.44 |
F508del/E822X | 3 | 2.58 |
F508del/621+1G>T | 3 | 2.58 |
F508del/R1066C | 3 | 2.58 |
F508del/G1349D | 2 | 1.72 |
F508del/G542X | 2 | 1.72 |
F508del/N1303K | 2 | 1.72 |
F508del/R1070Q | 1 | 0.86 |
F508del/S466X-R1070Q - in cis | 1 | 0.86 |
F508del/R1158X | 1 | 0.86 |
F508del /E831X | 1 | 0.86 |
6 | 5.17 | |
G542X/621+1G>T | 1 | 0.86 |
G85E/R1158X | 1 | 0.86 |
G542X/E822X | 1 | 0.86 |
621+1G>T/621+1G>T | 1 | 0.86 |
CFTR dele 2.3/1811+1G->C | 1 | 0.86 |
S466X-R1070Q in cis / E822X | 1 | 0.86 |
Incidence of Cystic fibrosis in Albania
1992–2017 | 1144138 | 285 | 1:4014 |
Overview data about patient with CF in Albania*
No. of patients | 133 | 100 |
Male | 72 | 54.14 |
Female | 61 | 45.86 |
Mean Age (years) at follow up. (Min-max) |
10.5 0.5–28.0 |
|
Mean Age (years) at diagnosis. (Min-max) |
0.75 0.0–16.0 |
|
No. of patients <18 years | 115 | 86.47 |
No. of patients > 18 years | 18 | 13.53 |
Homozygote for F508del | 87 | 65.41 |
Compound heterozygous mutation F508del | 23 | 17.29 |
Non-F508 mutation patients | 6 | 4.51 |
One determined mutation | 6 | 4.51 |
Unexamined | 11 | 8.27 |
Mean BMI Z-score: ± SD. >18 years old <18 years old |
−1.2 −0.7 |
|
Mean FEV1 (% predicted) | 89.7 | |
Chronic |
39 | 29.32 |
Chronic |
33 | 24.8 |
CF liver disease | 54 | 40.60 |
CF-related diabetes | 6 | 4.51 |
Pancreatic sufficient cases | 3 | 2.2 |
Allele frequencies in 122 Albanian patients and Classes according to their effect on the synthesis and/or function of the CFTR protein_
F508del, c.1521_1523delCTT, p. Phe508del | deletion | II | 203(83.19) |
621+1G>T, c.489+1G>T | splicing | I | 6 (2.45) |
E822X, c.2464G>T, p. Glu822Ter | nonsense | I | 5 (2.04) |
G85E, c.254G>A, p. Gly85Glu | missense | II | 5 (2.04) |
G542X (c.1624G>T) p. Gly542Ter | nonsense | I | 4 (1.63) |
R1066C, c.3196C>T, p. Arg1066Cys | missense | II | 3 (1.22) |
missense | Unclassified | 3 (1.22) | |
R1158X, c.3472C>T, p. Arg1158Ter | nonsense | I | 2 (0.81) |
G1349D, c.4046G>A p. Gly1349Asp | missense | III | 2 (0.81) |
N1303K, (c.3909C>G), p. Asn1303Lys | missense | II | 2 (0.81) |
nonsense | I | 2 (0.81) | |
1811+1G->C, c.1679+1G>C | splicing | V | 1 (0.40) |
E831X, c.2491G>T, p. Glu831X | nonsense | I | 1 (0.40) |
CFTRdele2-3(21kb), c.54-5940_273 + 10250 del, p. Ser18Argfs*16 | deletion | I | 1 (0.40) |